27.6.2023
References
Avail advised Nordic Bioproducts Group on the EUR 30 million funding round by Taaleri’s bioindustry fund, Chilean CMPC and other investors

Avail advised Sentica-backed Hammas Hohde on its acquisition of Turku-based dental clinic Kasinonkulman Hammaslääkärit. Hohde Group has previously operated in Turku with Loisto Laboratoriot’s two dental laboratory units and the acquisition expands Hohde Group’s service offering in the Turku region to include also dental care.